The estimated Net Worth of Paul A Laviolette is at least $723 Thousand dollars as of 15 May 2015. Mr. Laviolette owns over 5,668 units of Asensus Surgical Inc stock worth over $8,168 and over the last 17 years he sold ASXC stock worth over $549,968. In addition, he makes $165,036 as Independent Chairman of the Board at Asensus Surgical Inc.
Sign up
Mr. LaViolette ASXC stock SEC Form 4 insiders trading
Paul has made over 4 trades of the Asensus Surgical Inc stock since 2007, according to the Form 4 filled with the SEC. Most recently he sold 5,668 units of ASXC stock worth $253,360 on 15 May 2015.
The largest trade he's ever made was exercising 56,000 units of Asensus Surgical Inc stock on 31 October 2007 worth over $581,840. On average, Paul trades about 2,079 units every 81 days since 2007. As of 15 May 2015 he still owns at least 23,477 units of Asensus Surgical Inc stock.
You can see the complete history of Mr. Laviolette stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Paul LaViolette biography
Paul A. LaViolette serves as Independent Chairman of the Board of the Company. Mr. LaViolette has served as Chairman of our Board since September 2013. Mr. LaViolette is Managing Partner and Chief Operating Officer at SV Health Investors (SVHI), a medical device value fund. He joined SVHI in 2009 and has over 38 years of global medical technology management experience. Prior to joining SVHI, Mr. LaViolette was most recently Chief Operating Officer at Boston Scientific Corporation (BSC), an $8 billion medical device leader. During his 15 years at BSC, he served as COO, Group President, Cardiovascular, Group President, EndoSurgery, President-Cardiology and President-International. Mr. LaViolette integrated two dozen acquisitions and led extensive product development, operations and worldwide commercial organizations as the company grew 20-fold. Mr. LaViolette previously held marketing and general management positions at CR Bard, and various marketing roles at Kendall (Covidien). Mr. LaViolette serves on the boards of Axon Therapies, Bardy Diagnostics, Inc., Cardiofocus, Inc., CSA Medical Inc., Corvia Medical, Inc., Endotronix, Inc., Soffio Medical, Inc., Solsys Medical (formerly known as Soluble Solutions, Inc.), Stimwave LLC, ValenTx, Inc., and Ximedica, each of which are privately-held, as well as the Medical Device Manufacturers Association. Mr. LaViolette received his B.A. in Psychology from Fairfield University and his MBA from Boston College. Mr. LaViolette’s broad experience and keen business judgment qualify him to serve on our Board, and as the Chairman of our Board. Mr. LaViolette’s vast medical device operating experience makes him knowledgeable in the areas of product launches, new product development, clinical and regulatory affairs, plant management, quality systems, international sales and marketing, acquisitions and integrations and the analysis of investment opportunities.
What is the salary of Paul LaViolette?
As the Independent Chairman of the Board of Asensus Surgical Inc, the total compensation of Paul LaViolette at Asensus Surgical Inc is $165,036. There are 3 executives at Asensus Surgical Inc getting paid more, with Anthony Fernando having the highest compensation of $2,176,430.
How old is Paul LaViolette?
Paul LaViolette is 62, he's been the Independent Chairman of the Board of Asensus Surgical Inc since 2013. There are 4 older and 8 younger executives at Asensus Surgical Inc. The oldest executive at Asensus Surgical Inc is William Kelley, 80, who is the Independent Director.
What's Paul LaViolette's mailing address?
Paul's mailing address filed with the SEC is C/O PULSE BIOSCIENCES, INC., 3957 POINT EDEN WAY, HAYWARD, CA, 94545.
Insiders trading at Asensus Surgical Inc
Over the last 11 years, insiders at Asensus Surgical Inc have traded over $32,677,440 worth of Asensus Surgical Inc stock and bought 7,457,173 units worth $15,992,743 . The most active insiders traders include Jane Ph D Hsiao, Anthony C. J. Fernando, and William N Jr Starling. On average, Asensus Surgical Inc executives and independent directors trade stock every 46 days with the average trade being worth of $97,582. The most recent stock trade was executed by Rampertab Shameze on 21 April 2024, trading 81,521 units of ASXC stock currently worth $28,361.
What does Asensus Surgical Inc do?
asensus aps is a computer software company based out of 22a vallensbækvej, brondby, capital region of denmark, denmark.
What does Asensus Surgical Inc's logo look like?
Complete history of Mr. Laviolette stock trades at Misonix Inc, Pulse Biosciences Inc, Boston Scientific, Edwards Lifesciences Corp, and Asensus Surgical Inc
Asensus Surgical Inc executives and stock owners
Asensus Surgical Inc executives and other stock owners filed with the SEC include:
-
Anthony Fernando,
President, Chief Executive Officer, Director -
Anthony Fernando,
Pres, CEO & Director -
Shameze Rampertab B.Sc. MBA, CA, CPA,
Exec. VP & CFO -
Paul LaViolette,
Independent Chairman of the Board -
Richard Pfenniger,
Independent Director -
David Milne,
Independent Director -
William Starling,
Independent Director -
William Kelley,
Independent Director -
Jane Hsiao,
Independent Director -
Andrea Biffi,
Independent Director -
Shameze Rampertab,
Chief Financial Officer, Executive Vice President -
Dr. Stephanie M. Fitts,
VP of Clinical, Quality and Regulatory Affairs -
Amanda Owens,
Global Head of People -
Paul Ziegler Jr.,
VP of Sales -
Joshua B. Weingard,
Chief Legal Officer & Sec. -
Eric A Smith,
Chief Commercial Officer -
Joseph P Slattery,
EVP and CFO -
Aftab Kherani,
Director -
Willam N Kelley,
Director -
Todd Pope,
President and CEO -
S.P.A Sofar,,
10% owner -
Brett Farabaugh,
Interim CFO -
Capital Iii Lp Aisling Capi...,
-
Iv, Llcsv Life Sciences Fun...,
-
Dennis Dougherty,
Director -
Richard Mueller,
Chief Operating Officer -
Kevin J Hobert,
Director -
Elizabeth Kwo,
Director